Adam Kotowski

Research activity per year

Fingerprint

Dive into the research topics where Adam Kotowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Finished

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study with a Long-Term OpenLabel Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients with Hemophilic Arthropathy
Kotowski, A. (PI)
IQVIA Incorporated
05/31/22 → 12/31/25
Project: Research
Screening and Lead-in Observational Protocol to Determine Potential Patient Eligibility for Inclusion in AAV Gene Therapy Clinical Trials in Haemophilia B (ECLIPSE)
Kotowski, A. (PI)
Medpace LLC
05/20/21 → 08/25/24
Project: Research
Phase Ill, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno-associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AA VS-hFIXco-Padua, AMT-061) administered
Kotowski, A. (PI)
uniQure Biopharma BV
05/1/19 → 12/31/23
Project: Research

2 Article

Secondary tumors of the pancreas: Case report and a single-center experience
Dewanwala, A., Kotowski, A., Levea, C. M. & Ma, W. W., Sep 2012, In: Journal of Gastrointestinal Cancer. 43, SUPPL. 1, p. S117-S124
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels
Czuczman, M. S., Olejniczak, S., Gowda, A., Kotowski, A., Binder, A., Kaur, H., Knight, J., Starostik, P., Deans, J. & Hernandez-Ilizaliturri, F. J., Mar 1 2008, In: Clinical Cancer Research. 14, 5, p. 1561-1570 10 p.
Research output: Contribution to journal › Article › peer-review
218 Scopus citations

Adam Kotowski

Personal profile

Fingerprint

Grants & Projects

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study with a Long-Term OpenLabel Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients with Hemophilic Arthropathy

Screening and Lead-in Observational Protocol to Determine Potential Patient Eligibility for Inclusion in AAV Gene Therapy Clinical Trials in Haemophilia B (ECLIPSE)

Phase Ill, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno-associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AA VS-hFIXco-Padua, AMT-061) administered

Research output

Secondary tumors of the pancreas: Case report and a single-center experience

Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels